These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. Hydes TJ; Summers N; Brown E; Alam U; Thomaides-Brears H; Wilding JPH; Cuthbertson DJ Diabet Med; 2020 Nov; 37(11):1793-1806. PubMed ID: 32619031 [TBL] [Abstract][Full Text] [Related]
5. Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease. Lin CH; Kohli R Curr Gastroenterol Rep; 2020 Aug; 22(10):52. PubMed ID: 32814993 [TBL] [Abstract][Full Text] [Related]
6. Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design. Rudolph B; Bjorklund N; Ovchinsky N; Kogan-Liberman D; Perez A; Liszewski M; Levin TL; Ewart M; Liu Q; Xue X; Viswanathan S; Strickler HD Contemp Clin Trials; 2018 Dec; 75():51-58. PubMed ID: 30401631 [TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges. Goldner D; Lavine JE Gastroenterology; 2020 May; 158(7):1967-1983.e1. PubMed ID: 32201176 [TBL] [Abstract][Full Text] [Related]
8. The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease. Mandelia C; Kabbany MN; Conjeevaram Selvakumar PK; Alkhouri N Biomark Med; 2018 Mar; 12(3):265-273. PubMed ID: 29517271 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model". Fang YL; Chen H; Wang CL; Liang L World J Gastroenterol; 2018 Jul; 24(27):2974-2983. PubMed ID: 30038464 [TBL] [Abstract][Full Text] [Related]
11. Current Concepts in Pediatric Nonalcoholic Fatty Liver Disease. Fleet SE; Lefkowitch JH; Lavine JE Gastroenterol Clin North Am; 2017 Jun; 46(2):217-231. PubMed ID: 28506362 [TBL] [Abstract][Full Text] [Related]
12. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322 [TBL] [Abstract][Full Text] [Related]
13. KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Korean Association for the Study of the Liver (KASL) Clin Mol Hepatol; 2013 Dec; 19(4):325-48. PubMed ID: 24459637 [No Abstract] [Full Text] [Related]
14. Diagnosis and management of non-alcoholic fatty liver disease. Jennison E; Patel J; Scorletti E; Byrne CD Postgrad Med J; 2019 Jun; 95(1124):314-322. PubMed ID: 31085617 [TBL] [Abstract][Full Text] [Related]
15. Non-Invasive Diagnosis of Nonalcoholic Fatty Liver Disease. Yoneda M; Imajo K; Nakajima A Am J Gastroenterol; 2018 May; 113(10):1409-1411. PubMed ID: 29937542 [No Abstract] [Full Text] [Related]
17. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. Clemente MG; Mandato C; Poeta M; Vajro P World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650 [TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. Hassan K; Bhalla V; El Regal ME; A-Kader HH World J Gastroenterol; 2014 Sep; 20(34):12082-101. PubMed ID: 25232245 [TBL] [Abstract][Full Text] [Related]
19. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. Zhou JH; Cai JJ; She ZG; Li HL World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425 [TBL] [Abstract][Full Text] [Related]